Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information... Show more
FLGT is expected to report earnings to fall 403.29% to -21 cents per share on November 05
Q3'25
Est.
$-0.21
Q2'25
Beat
by $0.25
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.43
Q3'24
Beat
by $0.46
The last earnings report on August 01 showed earnings per share of 7 cents, beating the estimate of -18 cents. With 65.33K shares outstanding, the current market capitalization sits at 623.20M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FLGT showed earnings on August 01, 2025. You can read more about the earnings report here.